Weyerhaeuser Co Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $6.9B-3.8% YoYTTM through 30 Jun 2026
Net Income $472M+19.2% YoYTTM through 30 Jun 2026
Free Cash Flow $458MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | 14.3% |
| Net Margin | 6.9% |
Returns
5.0%ROE
2.9%ROA
3.2%ROIC
Balance Sheet Health
Debt / Equity0.57x
Current Ratio1.82x
Net Debt$5.1B
Cash & Equivalents$527M
Quality Metrics
Altman Z-Score2.08
Piotroski F-Score6 / 9
FCF Margin6.7%
Rule of 4011.8
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $6.9B
Diluted EPS$0.66TTMFY2025: $0.45
Dividend
$0.84Per share, FY20263.90%Yield2 yrsStreak-3.6%5-yr growth
Capital Allocation
R&D Spend$5M
Capex Intensity1.3%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.